Belinostat is a histone deacetylase (HDAC) inhibitor used in the treatment of certain types of cancer. It works by inhibiting the activity of HDAC enzymes, which play a crucial role in the regulation of gene expression. By blocking these enzymes, belinostat can induce cell cycle arrest, apoptosis, and differentiation in cancer cells, thereby inhibiting their growth and proliferation.
